text
"['\n4. 매출 및 수주상황\n1) 매출에 관한 사항(연결기준)\n가. 매출실적\n(단위 : 천원)\n사업부문\n매출유형\n품 목\n\xa0제6기 반기\n\xa0제5기\n\xa0제4기\n의약품제조\n제품\n넥실렌\n내수\n3,501,350\n10,197,180\n11,483,950\n란스톤 캡슐\n내수\n3,843,300\n6,650,092\n7,746,055\n비유피-4정\n내수\n3,204,469\n6,245,158\n6,154,792\n클로피린 캡슐\n내수\n3,350,602\n6,564,365\n6,153,121\n크라비트주\n수출\n102,484\n183,682\n355,311\n내수\n2,299,864\n4,321,966\n5,452,808\n스타브론 정\n내수\n2,388,488\n5,968,898\n5,962,636\n베라실\n내수\n2,700,396\n5,817,961\n5,736,313\n옴니세프\n내수\n1,102,994\n3,523,816\n3,024,730\n티에스원 캡슐\n내수\n2,491,822\n5,454,509\n6,176,373\n야마테탄 주\n내수\n1,025,282\n2,672,750\n3,387,420\n필그렐정\n수출\n-\n-\n-\n내수\n3,397,897\n6,150,724\n5,886,600\n크라비트정\n내수\n1,327,168\n2,670,276\n3,529,480\n리피토플러스\n내수\n3,906,693\n3,359,900\n-\n기타\n수출\n13,914,541\n20,786,673\n28,025,112\n내수\n26,173,334\n47,609,043\n52,710,576\n합계\n40,087,875\n68,395,716\n80,735,688\n소계\n수출\n14,017,025\n20,970,355\n28,380,423\n내수\n60,713,659\n117,206,638\n123,404,854\n합계\n74,730,684\n138,176,993\n151,785,277\n상품\n리피토 정\n내수\n90,790,485\xa0\n176,606,941\n168,564,373\n리리카 캡슐\n내수\n35,170,924\xa0\n66,982,277\n64,726,691\n쎄레브렉스 캡슐\n내수\n23,773,950\xa0\n47,318,841\n45,683,278\n란스톤 LFDT 정\n내수\n12,493,696\xa0\n29,921,078\n31,464,776\n네시나 정\n내수\n22,253,176\xa0\n32,329,547\n33,011,509\n뉴론틴 정\n내수\n12,075,376\xa0\n23,741,407\n22,399,534\n카듀엣 정\n내수\n9,517,751\xa0\n18,484,886\n18,940,655\n액토스 정\n내수\n14,527,599\xa0\n21,723,180\n21,740,264\n덱실란트 디알 캡슐\n내수\n10,909,243\xa0\n17,528,588\n18,212,618\n기타\n수출\n22,085\n349,204\n1,493,655\n내수\n66,958,267\n124,758,273\n110,748,021\n합계\n66,980,352\n125,107,477\n112,241,676\n소계\n수출\n22,085\n349,204\n1,493,655\n내수\n298,470,467\n559,395,018\n535,491,719\n합계\n298,492,552\n559,744,222\n536,985,374\n기타\n수탁시험외\n내수\n1,447,460\n2,772,014\n2,554,186\n합 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0계\n수출\n14,039,110\n21,319,559\n29,874,078\n내수\n360,631,586\n679,373,670\n661,450,759\n합계\n374,670,696\n700,693,229\n691,324,837\n나. 판매경로 및 판매방법 등\n(1) 판매조직 - 사업의 개요에 첨부한 조직도 참조\n(2) 판매경로\n\xa0원외 \xa0 \xa0 \xa0 : \xa0 85.5% \xa0 \xa0 \xa0 종합병원 : \xa0 \xa07.6% \xa0 \xa0 \xa0 \xa0 \xa0관계사 \xa0 \xa0: \xa0 \xa0 0.8%  기타 \xa0 \xa0 \xa0 : \xa0 \xa02.6% \xa0 \xa0 \xa0 \xa0수출 \xa0 \xa0 \xa0 : \xa0 \xa03.5%(3) 판매방법 및 조건\n\xa0 방법 : 주문판매 \xa0조건 : 외상매출후 현금, 어음, 카드등 수금(4) 판매전략\n\xa0 \xa0 \xa01. Product Specialist 제도 운영으로 마케팅력의 극대화 \xa0 \xa0 2. 학술세미나, 제품설명회의 확대로 고객만족 마케팅 전개 \xa0 \xa0 3. 정도의 영업지향 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa04. 제품별 시장 차별화 전략\n']"
